Giving a personal touch to EHRs, healthcare tech

Cara Livernois | | Health Exec | Economics

Technology has taken the healthcare industry by storm, but the replacement of human interaction by digital health leaves patients feeling cold and left behind.

Rothman Healthcare analyzed the available clinical data and developed the Rothman Index (RI) model, which synthesizes EHR data into actionable information for care providers in the form of a health score measuring a patient’s overall condition and plotting it over time.

According to the article in Forbes, "the RI model uses a range of physiological measures as inputs, including labs, vitals, and nursing assessments to produce a disease-agnostic, universal patient score from 0-100 that is presented in color-coded graphs trended over time."

Read the full article by clicking the link below:

 

 

Medical Tech Or Personal Touch? PeraHealth Has Cracked The Code

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Compensation jumps 6% for heart surgeons, hits all-time high for vascular surgeons
Bipartisan group of 233 House members call for Medicare reform
Wartime powers enacted to address nationwide IV fluid shortage
Cardiologist compensation still rising, especially in invasive and interventional cardiology
Baxter begins importing IV supplies as 86% of providers report shortages
CMS proposes rule to combat gray market health insurance scams

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup